injectable glucagon-like peptide-1 (GLP-1) receptor agonistsoral treatment
…the weight gain commonly seen when patients stop treatment with injectable glucagon-like peptide-1 (GLP-1) receptor agonists, a study has found.…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…the weight gain commonly seen when patients stop treatment with injectable glucagon-like peptide-1 (GLP-1) receptor agonists, a study has found.…